However, so far across studies with GLP1R agonists , cardiovascular measurements such as blood pressure have seen improvements in general, with no significant increases in adverse cardiovascular effects seen in patients even after 2 years (In fact, decreases were seen), suggesting that the cardiovascular benefits of decreased body weight may overcome any potential harm that increases in heart rate by GLP1R agonists may cause
Duerschmied, D
[DOI] [PMC free article] [PubMed] [Google Scholar] 56.Mayo J.C., Sainz R.M., Tan D.X., Hardeland R., Leon J., Rodriguez C., Reiter R.J
Biochem Cell Biol (2010) 88:72330
Gavin Creel passed away two months after being diagnosed with metastatic melanotic peripheral nerve sheath sarcoma, highlighting the aggressive nature of this rare cancer